SCG3 and cancer: Importantly, the outcomes of reconstituting DAPk in target cells, for example by the recombinant immunokinase DK1KD-SGIII (a revised DAPk1), is marked by a robust catalytic activity (in inducing apoptosis) in vitro, in vivo, and in primary cells from cancer patients [47].